Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Probiotics prevent hepatic encephalopathy in patients with cirrhosis

A study in this month's Clinical Gastroenterology & Hepatology evaluates the use of probiotics for hepatic encephalopathy in patients with cirrhosis.

News image

Hepatic encephalopathy is associated with a poor prognosis in patients with advanced liver disease. Probiotics alter the intestinal microbiota with non–urease-producing organisms that reduce production of ammonia.

Dr Barjesh Chander Sharma and colleagues from India investigated the efficacy of probiotics for the primary prophylaxis of hepatic encephalopathy.

The research team conducted a prospective trial at a tertiary care referral institute in New Delhi, India, from 2012 through 2013, of patients with cirrhosis without overt hepatic encephalopathy.

Subjects were assigned randomly to groups given probiotics or no test article.

All subjects underwent psychometric analyses, critical flicker fusion threshold assessments, glucose hydrogen breath tests to identify small intestinal bacterial overgrowth, and lactulose hydrogen breath tests to measure orocecal transit time.

Probiotic administration increased psychometric hepatic encephalopathy scores
Clinical Gastroenterology & Hepatology

The team's primary end point was the development of overt hepatic encephalopathy.

At baseline, subjects in each group had comparable CTP score, model for end-stage liver disease scores, critical flicker fusion assessments, psychometric hepatic encephalopathy scores, and orocecal transit time.
 
The team found that after a mean follow-up period of 39 weeks for patients given probiotics and 40 weeks for controls, 6 patients given probiotics and 7 controls died.

The research team observed that 3 months of probiotic administration significantly reduced levels of arterial ammonia, small intestinal bacterial overgrowth, and orocecal transit time.

The team also found that probiotic administration increased psychometric hepatic encephalopathy scores, and increased critical flicker fusion thresholds, compared with baseline.

The researchers noted that 7 subjects in the probiotic group and 14 controls developed overt hepatic encephalopathy.

Psychometric hepatic encephalopathy scores, CTP scores, and small intestinal bacterial overgrowth correlated with the development of overt hepatic encephalopathy.

Dr Sharma and team comment, "In a prospective, randomized controlled trial, probiotics were found to be effective in preventing hepatic encephalopathy in patients with cirrhosis."

Clin Gastroenterol Hepatol 2014: 12(6): 1003–1008.e1
04 June 2014

Go to top of page Email this page Email this page to a colleague

 04 August 2015

Advanced search
 04 August 2015 
IBD environmental risk factors
 04 August 2015 
Measuring disease activity in Crohn's
 04 August 2015 
Gastric emptying and hyperglycemia in diabetes
 03 August 2015 
Vaccinations and IBD
 03 August 2015 
Lack of response to therapy in severe ulcerative colitis
 03 August 2015 
Nutritional vs biological therapy in Crohn's
 31 July 2015 
Prognostic index for hep C-related cirrhosis
 31 July 2015 
Risk of hepatocellular carcinoma in chronic HCV with diabetes
 31 July 2015 
Reducing surgical site infection after stoma reversal
 30 July 2015 
Post-colonoscopy colorectal cancer rates
 30 July 2015 
Venous thromboembolism in colorectal surgery
 30 July 2015 
Saccharomyces boulardii for antibiotic-associated diarrhea
 29 July 2015 
Sitafloxacin-based triple therapy for H.pylori
 28 July 2015 
Lifestyle changes after colorectal cancer screening
 27 July 2015 
Fecal microbiota transplantation for severe C. difficile infection
 24 July 2015 
Causes of death in celiac disease
 23 July 2015 
Reduction in H. pylori prevalence
 22 July 2015 
Detection of esophageal eosinophilia and eosinophilic esophagitis
 21 July 2015 

Clinical outcomes for Barrett's esophagus neoplasia

 20 July 2015 
Certolizumab pegol for Crohn's disease
 17 July 2015 
Genetic variation and gastric cancer
 17 July 2015 
Colitis associated with anti-CTLA-4 therapy
 17 July 2015 

Sexual dysfunction after rectal cancer treatment

 16 July 2015 
Lynch syndrome screening by microsatellite instability
 16 July 2015 
Hormones and endometrial cancer in Lynch syndrome
 16 July 2015 
Relapse of IBD after discontinuation of anti-TNF therapy
 15 July 2015 
Risk prediction index for advanced colorectal cancer
 15 July 2015 
Aspergillus niger-derived enzymes
 15 July 2015 
Prophylactic omeprazole improves GI symptoms
 14 July 2015 
Interferon- and ribavirin-free treatment regimen for HCV
 14 July 2015 
Combination therapies for chronic HCV
 14 July 2015 
Cancer surveillance in ulcerative colitis
 13 July 2015 
Colon polyps in chronic inflammatory conditions of the colon
 13 July 2015 
Drugs and occult vs overt upper GI bleeds
 13 July 2015 
Anxiety and depression in functional GI disorders
 10 July 2015 
Daclatasvir in the treatment of chronic HCV
 10 July 2015 
Surveillance intervals to reduce colorectal cancer
 10 July 2015 
Stress and GI symptoms in IBD
 09 July 2015 
Opioid-induced esophageal dysfunction
 09 July 2015 
Marker of response to medical therapy in Crohn's
 09 July 2015 
Predictive factors for metastasis in colorectal cancer
 08 July 2015 
Chronic unexplained nausea and vomiting
 08 July 2015 

Nucleoside analogue therapy in HBeAg-negative chronic hepatitis B?

 08 July 2015 

Medical education in endoscopy training

 07 July 2015 
Anastomotic leak after elective surgery for colonic cancer
 07 July 2015 
Fecal transplantation for ulcerative colitis
 07 July 2015 
Obesity and risk of hepatocellular carcinoma
 06 July 2015 
Fecal microbiota transplantation
 06 July 2015 
Liver Failure–Sequential Organ Failure Scoring System
 06 July 2015 
Future colorectal surgery for metachronous cancers
 03 July 2015 
Tumors with mismatch-repair deficiency
 03 July 2015 
Aptitude of trainees in endoscopic ultrasonography
 03 July 2015 
Extracolonic pathologies in colorectal cancer
 02 July 2015 
Ulcerative colitis prognosis after thiopurines withdrawal
 02 July 2015 
Anastomotic leak and cancer cancer
 02 July 2015 
Health care use by IBD children
 01 July 2015 
Missed gastric cancers
 01 July 2015 
Oral mechanical bowel preparation
 01 July 2015 
Probiotics in IBD
 30 June 2015 
Split-dose preparations vs day-before bowel cleansing regimens

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us